U.S. Markets closed

Omnicare cold be a takeout candidate, says Credit Suisse

Credit Suisse said Omnicare's Change in Control Plan leads it to speculate that there is outside interest in the company. The analyst believes Omnicare's improving operations in its Long-term Care Group and growing Specialty business makes it a potential target. Shares are Outperform rated with a $52 price target, up from $50.